baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out BMY/ DE000GG6HX15 /

04/06/2024 10:14:15	Chg.0.00	Bid16:17:50	Ask16:17:50	Underlying	Strike price	Expiration date	Option type
1.07EUR	0.00%	1.06 Bid Size: 200,000	1.07 Ask Size: 200,000	Bristol Myers Squibb...	53.502 USD	31/12/2078	Put

GlobeNewswire 31/05 Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...

GlobeNewswire 30/05 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...

GlobeNewswire 24/05 Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board

GlobeNewswire 23/05 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...

GlobeNewswire 23/05 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...

GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 22/05 Anavex Life Sciences Announces Expansion of Leadership Team

GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants

GlobeNewswire 15/05 Lantheus Announces Executive Appointments to Accelerate Innovation

GlobeNewswire 14/05 Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, Dav...

GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...

GlobeNewswire 13/05 Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update

GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/05 Immunocore reports first quarter financial results and provides a business update

GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 02/05 Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., ...

GlobeNewswire 01/05 Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

GlobeNewswire 30/04 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 30/04 CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical D...

GlobeNewswire 25/04 International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on A...

GlobeNewswire 25/04 Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract ...

GlobeNewswire 25/04 Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...

GlobeNewswire 22/04 ArriVent Appoints Kristine Peterson to its Board of Directors

GlobeNewswire 08/04 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Sq...

Goldman Sachs Knock-Out BMY/ DE000GG6HX15 /

If you wish to receive reply to your feedback, please provide your email address.